Fermenta Biotech Ltd — Important, 09-02-2026: Company Update

Fermenta Biotech announced strong consolidated financial results for 9MFY26, with revenue rising 25% to INR 421.2 crore and EBITDA up 20% to INR 97.2 crore. Net profit also increased 20% to INR 51.7 crore. This growth was primarily driven by the Vitamin D3 - Human Nutrition segment, which saw a 46% increase in volumes. The company approved a significant INR 110 crore capital expenditure at Dahej to expand production of plant-based Vitamin D3, green chemistry enzymes, and Vitamin D3 derivatives, strengthening its leadership in biocatalysis and Vitamin D3 innovation. Additionally, the Environment Division was transferred to a subsidiary for INR 19 crore.